[go: up one dir, main page]

GB202306601D0 - Inhibitor compounds - Google Patents

Inhibitor compounds

Info

Publication number
GB202306601D0
GB202306601D0 GBGB2306601.2A GB202306601A GB202306601D0 GB 202306601 D0 GB202306601 D0 GB 202306601D0 GB 202306601 A GB202306601 A GB 202306601A GB 202306601 D0 GB202306601 D0 GB 202306601D0
Authority
GB
United Kingdom
Prior art keywords
inhibitor compounds
inhibitor
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2306601.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Priority to GBGB2306601.2A priority Critical patent/GB202306601D0/en
Publication of GB202306601D0 publication Critical patent/GB202306601D0/en
Priority to CN202480045347.XA priority patent/CN121443594A/en
Priority to PCT/GB2024/051180 priority patent/WO2024228035A1/en
Priority to AU2024265368A priority patent/AU2024265368A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2306601.2A 2023-05-04 2023-05-04 Inhibitor compounds Ceased GB202306601D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2306601.2A GB202306601D0 (en) 2023-05-04 2023-05-04 Inhibitor compounds
CN202480045347.XA CN121443594A (en) 2023-05-04 2024-05-03 IKK-α inhibitors
PCT/GB2024/051180 WO2024228035A1 (en) 2023-05-04 2024-05-03 Ikk-alpha inhibitors
AU2024265368A AU2024265368A1 (en) 2023-05-04 2024-05-03 Ikk-alpha inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2306601.2A GB202306601D0 (en) 2023-05-04 2023-05-04 Inhibitor compounds

Publications (1)

Publication Number Publication Date
GB202306601D0 true GB202306601D0 (en) 2023-06-21

Family

ID=86763229

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2306601.2A Ceased GB202306601D0 (en) 2023-05-04 2023-05-04 Inhibitor compounds

Country Status (4)

Country Link
CN (1) CN121443594A (en)
AU (1) AU2024265368A1 (en)
GB (1) GB202306601D0 (en)
WO (1) WO2024228035A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
EP1289952A1 (en) 2000-05-31 2003-03-12 AstraZeneca AB Indole derivatives with vascular damaging activity
UA73993C2 (en) 2000-06-06 2005-10-17 Астразенека Аб Quinazoline derivatives for the treatment of tumours and a pharmaceutical composition
CA2411160A1 (en) 2000-07-07 2002-01-17 Angiogene Pharmaceuticals Limited Colchinol derivatives as vascular damaging agents
MXPA02012903A (en) 2000-07-07 2004-07-30 Angiogene Pharm Ltd Colchinol derivatives as angiogenesis inhibitors.
WO2008132121A1 (en) * 2007-04-26 2008-11-06 Glaxo Group Limited Lh-indazole-3-amine compounds as ikk1 inhibitors
US8648069B2 (en) * 2007-06-08 2014-02-11 Abbvie Inc. 5-substituted indazoles as kinase inhibitors
EP4522597A1 (en) * 2022-05-11 2025-03-19 Cancer Research Technology Limited Ikk inhibitors

Also Published As

Publication number Publication date
AU2024265368A1 (en) 2025-11-27
CN121443594A (en) 2026-01-30
WO2024228035A1 (en) 2024-11-07

Similar Documents

Publication Publication Date Title
IL324796A (en) Parp1 inhibitor compounds
GB202008201D0 (en) Inhibitor compounds
IL314049A (en) Parp7 inhibitors
GB202004960D0 (en) Inhibitor compounds
GB202200735D0 (en) Compounds
GB202110373D0 (en) Inhibitor compounds
GB202307924D0 (en) Inhibitor compounds
GB202300881D0 (en) Inhibitor compounds
GB202201996D0 (en) Compounds
GB202306601D0 (en) Inhibitor compounds
GB202215245D0 (en) Inhibitor compounds
GB202207972D0 (en) Inhibitor compounds
GB202117224D0 (en) Inhibitor compounds
GB202112240D0 (en) Inhibitor compounds
GB202107325D0 (en) Inhibitor compounds
GB202104781D0 (en) Inhibitor compounds
GB202016964D0 (en) Inhibitor compounds
GB202012969D0 (en) Inhibitor compounds
GB202008205D0 (en) Inhibitor compounds
IL325676A (en) Kat6 inhibitor
GB202418176D0 (en) Inhibitor compounds
GB202417501D0 (en) Inhibitor compounds
GB202401711D0 (en) Inhibitor compounds
IL317176A (en) Cd73 inhibitor compounds
HK40111094A (en) Inhibitor compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)